Exit interview with Fiona Godlee

Exit interview with Fiona Godlee

Author: The BMJ December 15, 2021 Duration: 43:48
Fiona Godlee is stepping down as Editor-in-Chief of The BMJ after 16 years in the position. She was the first female editor of the journal, and over her tenure has seen a lot of changes - both to the publication she's run, and to the wider world of medicine. To mark her departure, Helen Macdonald sat down with Fiona to ask her a bit about those early days at the journal, on her view of women taking leadership roles in medicine, on her thoughts about some of the big issues facing science, and what is coming next.

Note from the editor; apologies for the audio quality in the first half.


Produced by The BMJ, this weekly audio series delves into the pivotal research and urgent clinical debates shaping modern medicine. Each episode moves beyond the published page, bringing together the authors, critics, and practitioners directly involved to dissect a new study or a pressing health question. The conversation is rigorous and nuanced, designed for those who appreciate the complexity behind headlines. You’ll hear unscripted discussion about methodology, implications for practice, and the occasional healthy disagreement that drives science forward. This isn't just a summary of the latest findings; it's a critical appraisal in real time, offering listeners a front-row seat to the evolving discourse that defines evidence-based care. The Medicine and Science from The BMJ podcast serves as an essential audio companion for clinicians, academics, and anyone keen to understand the ‘why’ and ‘how’ behind medical news. It transforms the latest evidence from the journal into an accessible, thought-provoking dialogue, ensuring that busy professionals can stay deeply informed. Tune in for a direct, intelligent, and often surprising take on the science that matters most.
Author: Language: English Episodes: 1000

Medicine and Science from The BMJ
Podcast Episodes
Investigating UTIs in older adults [not-audio_url] [/not-audio_url]

Duration: 11:05
UTIs are often diagnosed in secondary care, but often that diagnosis isn't accurate. In this podcast Gavin Barlow from the Department of infection and tropical medicine at Hull & East Yorkshire Hospitals NHS Trust joins…
Alcohol - The UK’s billion unit pledge is worthless [not-audio_url] [/not-audio_url]

Duration: 19:45
The BMJ has been investigating the “cosy relationship” between the alcohol industry and the British government. In a series of articles Under the influence, journalist Jonathan Gornall has been looking into UK government…
Patient confidentiality in the digital age [not-audio_url] [/not-audio_url]

Duration: 17:59
Digital technology introduces new concerns for confidentiality and information security. In this podcast Bradley Crotty and Arash Mostaghimi, both from Harvard Medical School, outline the regulations governing confidenti…
The problems with testosterone testing in female athletes [not-audio_url] [/not-audio_url]

Duration: 17:56
The International Olympic Committee (IOC) and other international sports federations have recently introduced policies which require a medical investigation of women athletes known or suspected to have hyperandrogenism.…
Should doctors be prescribing cannabinoids? [not-audio_url] [/not-audio_url]

Duration: 18:54
Michael Farrell, professor and director of the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, talks to Mabel Chew, The BMJ's practice editor, about prescription of cannabinoids.…
Using HbA1c to diagnose type 2 diabetes [not-audio_url] [/not-audio_url]

Duration: 14:56
Glycated Haemoglobin (HbA1c) is used to measure glucose control in patients with diabetes, but can now be used as an alternative test to glucose concentration for diagnosing type 2 diabetes or identifying people at high…
How to manage the first seizure in an adult [not-audio_url] [/not-audio_url]

Duration: 29:43
First seizure covers a wide range of manifestations, but picking up the minor events can prevent a patient from experiencing a major event, so early diagnosis is key. Heather Angus-Leppan, consultant neurologist and epil…
Tamiflu US Press Conference [not-audio_url] [/not-audio_url]

Duration: 32:35
Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has sho…
Triptans for the acute treatment of migraine [not-audio_url] [/not-audio_url]

Duration: 17:32
Mabel Chew talks to Tamara Pringsheim, from the University of Calgary, about the use of triptans for acute treatment of migraine. When, how, and what contraindications a physician should be aware of. Read the full articl…